Close Menu

NEW YORK (360Dx) – SpeeDx said this week that its PlexPCR RespiVirus test has received regulatory clearance from the Australian Therapeutic Goods Administration. The assay uses PlexPCR technology to detect 11 viral respiratory illness-causing pathogens including influenza A, influenza B, rhinovirus, respiratory syncytial viruses (A and B), human metapneumovirus, adenovirus, and human parainfluenza viruses 1, 2, 3, and 4.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.